Warrant Exercise
-
Neotech Metals: VR Resources Shares Released from Escrow, Warrant Exercise Funds Received
Neotech Metals has successfully released VRS shares from escrow and received funds from warrant exercises. This strategic financial move injects capital, enhancing liquidity and operational flexibility. The company will utilize these resources for exploration, drilling, and acquiring new prospects, signaling strong market confidence and paving the way for accelerated growth and shareholder value.
-
bioAffinity Technologies Announces $1.2 Million Private Placement and Warrant Inducement Transaction
bioAffinity Technologies (BIAF, BIAFW) secured financing through securities purchase agreements with investors, involving the sale of Series B Convertible Preferred Stock and warrants to purchase common stock in a private placement. They also reached a warrant exercise agreement, generating $253,000. These transactions aim to raise approximately $1.2 million for working capital and general corporate purposes, supporting the development and commercialization of their CyPath® Lung test, a non-invasive early lung cancer detection method with reported 92% sensitivity. WallachBeth Capital LLC acted as placement agent.
-
SenesTech Announces Closing of $6.3 Million Warrant Exercise
SenesTech, Inc. (SNES), a biotech company specializing in fertility control for pest management, announced the closing of a warrant exercise generating $6.3 million. The company issued new short-term warrants priced at $0.125, potentially yielding an additional $11.5 million if fully exercised. SenesTech intends to use the net proceeds for working capital and general corporate initiatives. Their flagship product, ContraPest®, is a registered contraceptive for rats, aiming for humane and ecologically-sound pest control.
